* Reactions reported by a minimum of 1% of people treated with zolpidem tartrate prolonged-launch tablets and at greater frequency than while in the placebo group. This medicine could bring about respiratory depression, a significant respiration difficulty that could be daily life-threatening, when utilized along with opioid suffering medicines. Dihydrocodeine https://dihydrocodeine30mgsideeff24443.blogminds.com/details-fiction-and-co-codamol-30mg-500mg-30061739